Showing results (381-390 of 1,983) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|September 18, 2015
Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's diseaseMattia Volta, Austen J Milnerwood, Matthew J FarrerThe Lancet. Neurology|January 11, 2015
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisNanna B Finnerup, Nadine Attal, Simon Haroutounian, et al.The Lancet. Neurology|September 19, 2014
Connections between sleep and cognition in older adultsKristine Yaffe, Cherie M Falvey, Tina HoangThe Lancet. Neurology|July 18, 2014
The Glasgow Coma Scale at 40 years: standing the test of timeGraham Teasdale, Andrew Maas, Fiona Lecky, et al.The Lancet. Neurology|March 28, 2016
Neurological prognostication of outcome in patients in coma after cardiac arrestAndrea O Rossetti, Alejandro A Rabinstein, Mauro OddoThe Lancet. Neurology|March 28, 2016
Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association dataKin Y Mok, Una Sheerin, Javier Simón-Sánchez, et al.The Lancet. Neurology|April 13, 2016
Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studiesThe Lancet. Neurology|August 18, 2017
Paroxysmal sympathetic hyperactivity: the storm after acute brain injuryGeert Meyfroidt, Ian J Baguley, David K MenonThe Lancet. Neurology|July 18, 2017
Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trialMarc Tardieu, Michel Zérah, Marie-Lise Gougeon, et al.The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.Pageof 199